Teva reports positive outcomes from episodic migraine trial in young patients

Teva reports positive outcomes from episodic migraine trial in young patients

Submitted by admin on December 5, 2024 - 11:18am
Source: 
Clinical Trials Arena
News Tags: 
Teva Pharmaceutical
Ajovy
episodic migraines
migraines
clinical trials
Headline: 
Teva reports positive outcomes from episodic migraine trial in young patients
snippet: 

Teva Pharmaceutical Industries has reported positive outcomes from its multicentre Phase III SPACE trial of Ajovy (fremanezumab) as a preventive treatment for episodic migraine in young individuals aged six to 17 years.

Do Not Allow Advertisers to Use My Personal information